19-55489395-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001144950.2(SSC5D):c.94C>T(p.Arg32Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000269 in 1,484,344 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00016 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000011 ( 0 hom. )
Consequence
SSC5D
NM_001144950.2 missense
NM_001144950.2 missense
Scores
8
8
3
Clinical Significance
Conservation
PhyloP100: 0.230
Genes affected
SSC5D (HGNC:26641): (scavenger receptor cysteine rich family member with 5 domains) Predicted to enable fibronectin binding activity; laminin binding activity; and scavenger receptor activity. Predicted to be involved in defense response; detection of bacterial lipoprotein; and negative regulation of interleukin-8 production. Predicted to act upstream of or within regulation of interleukin-8 production. Predicted to be located in collagen-containing extracellular matrix. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.828
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SSC5D | NM_001144950.2 | c.94C>T | p.Arg32Cys | missense_variant | 3/14 | ENST00000389623.11 | NP_001138422.1 | |
SSC5D | NM_001195267.2 | c.94C>T | p.Arg32Cys | missense_variant | 3/13 | NP_001182196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SSC5D | ENST00000389623.11 | c.94C>T | p.Arg32Cys | missense_variant | 3/14 | 1 | NM_001144950.2 | ENSP00000374274.4 | ||
SSC5D | ENST00000587166.5 | c.94C>T | p.Arg32Cys | missense_variant | 3/13 | 1 | ENSP00000467252.1 | |||
SSC5D | ENST00000594321.5 | c.94C>T | p.Arg32Cys | missense_variant | 3/3 | 4 | ENSP00000470226.1 | |||
SSC5D | ENST00000588254.1 | n.508C>T | non_coding_transcript_exon_variant | 2/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152224Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
25
AN:
152224
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000113 AC: 15AN: 1332004Hom.: 0 Cov.: 31 AF XY: 0.00000305 AC XY: 2AN XY: 655426
GnomAD4 exome
AF:
AC:
15
AN:
1332004
Hom.:
Cov.:
31
AF XY:
AC XY:
2
AN XY:
655426
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152340Hom.: 1 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74498
GnomAD4 genome
AF:
AC:
25
AN:
152340
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.94C>T (p.R32C) alteration is located in exon 3 (coding exon 3) of the SSC5D gene. This alteration results from a C to T substitution at nucleotide position 94, causing the arginine (R) at amino acid position 32 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
.;H;H
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
.;.;D
REVEL
Uncertain
Sift
Pathogenic
.;.;D
Sift4G
Pathogenic
D;D;D
Polyphen
1.0
.;.;D
Vest4
0.71, 0.72
MutPred
Loss of methylation at R32 (P = 0.0265);Loss of methylation at R32 (P = 0.0265);Loss of methylation at R32 (P = 0.0265);
MVP
MPC
0.11
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at